NO952601L - Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser - Google Patents
Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaserInfo
- Publication number
- NO952601L NO952601L NO952601A NO952601A NO952601L NO 952601 L NO952601 L NO 952601L NO 952601 A NO952601 A NO 952601A NO 952601 A NO952601 A NO 952601A NO 952601 L NO952601 L NO 952601L
- Authority
- NO
- Norway
- Prior art keywords
- oligonucleotides
- expression
- inhibition
- protein transferases
- isoprenyl protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01029—Geranylgeranyl diphosphate synthase (2.5.1.29)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Abstract
Oppfinnelsen vedrører oligonukleotider og deres derivater for inhibering av ekspresjonen av isoprenylprotein-: transferaser, terapeutiske blandinger som inneholder slike forbindelser og anvendelsen av slike blandinger av oligonukleotider til behandling eller terapi av sykdommer hos dyr eller mennesker, indusert gjennom en abnorm og/eller ukontrollert cellulær proliferasjon.i
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9413035A GB9413035D0 (en) | 1994-06-29 | 1994-06-29 | Antisense oligonucleeotides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952601D0 NO952601D0 (no) | 1995-06-28 |
NO952601L true NO952601L (no) | 1996-01-02 |
Family
ID=10757497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952601A NO952601L (no) | 1994-06-29 | 1995-06-28 | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser |
Country Status (25)
Country | Link |
---|---|
US (1) | US5856461A (no) |
EP (1) | EP0692535A1 (no) |
JP (1) | JPH0851985A (no) |
KR (1) | KR960000914A (no) |
CN (1) | CN1124142A (no) |
AU (1) | AU689887B2 (no) |
BR (1) | BR9503015A (no) |
CA (1) | CA2152233A1 (no) |
CZ (1) | CZ291496B6 (no) |
DZ (1) | DZ1903A1 (no) |
FI (1) | FI953170A (no) |
FR (2) | FR2721930B1 (no) |
GB (2) | GB9413035D0 (no) |
HU (1) | HU219823B (no) |
IE (1) | IE950477A1 (no) |
MA (1) | MA23595A1 (no) |
NO (1) | NO952601L (no) |
NZ (1) | NZ272398A (no) |
OA (1) | OA10221A (no) |
PL (1) | PL309384A1 (no) |
RU (1) | RU2112766C1 (no) |
SE (1) | SE9502259L (no) |
SK (1) | SK83895A3 (no) |
TN (1) | TNSN95068A1 (no) |
ZA (1) | ZA955288B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11509204A (ja) * | 1995-07-13 | 1999-08-17 | ユニバーシテイ・オブ・シンシナテイ | 神経線維腫症の治療に有用な化合物 |
CN1301731A (zh) * | 1999-12-24 | 2001-07-04 | 上海博德基因开发有限公司 | 一种新的多肽——多异戊二烯基合成酶蛋白9和编码这种多肽的多核苷酸 |
WO2002046414A2 (en) * | 2000-12-07 | 2002-06-13 | Bristol-Myers Squibb Company | Human g-protein coupled receptor expressed highly in kidney |
US20030212017A1 (en) * | 2002-05-10 | 2003-11-13 | Isis Pharmaceuticals Inc. | Antisense modulation of farnesyl transferase beta subunit expression |
US7507808B2 (en) * | 2002-12-12 | 2009-03-24 | Isis Pharmaceuticals, Inc. | Modulation of endothelial lipase expression |
DK1667522T3 (en) * | 2003-09-09 | 2018-03-05 | Geron Corp | MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION |
WO2008094640A2 (en) * | 2007-01-30 | 2008-08-07 | Geron Corporation | Compounds having anti-adhesive effects on cancer cells |
JOP20200257A1 (ar) | 2014-05-01 | 2017-06-16 | Geron Corp | تركيبات أوليجو نوكليوتيد وطرق لتحضيرها |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571421A (en) * | 1979-11-05 | 1986-02-18 | Genentech, Inc. | Mammalian gene for microbial expression |
US5004803A (en) * | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
US5420245A (en) * | 1990-04-18 | 1995-05-30 | Board Of Regents, The University Of Texas | Tetrapeptide-based inhibitors of farnesyl transferase |
US5185248A (en) * | 1990-05-08 | 1993-02-09 | E. R. Squibb & Sons, Inc. | Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation |
EP0575491B1 (en) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
NZ244820A (en) * | 1991-10-25 | 1994-01-26 | Isis Pharmaceuticals Inc | Oligonucleotide inhibitor of epstein-barr virus. |
US5348853A (en) * | 1991-12-16 | 1994-09-20 | Biotronics Corporation | Method for reducing non-specific priming in DNA amplification |
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
-
1994
- 1994-06-29 GB GB9413035A patent/GB9413035D0/en active Pending
-
1995
- 1995-06-20 CA CA002152233A patent/CA2152233A1/en not_active Abandoned
- 1995-06-21 NZ NZ272398A patent/NZ272398A/en unknown
- 1995-06-21 SE SE9502259A patent/SE9502259L/xx not_active Application Discontinuation
- 1995-06-21 FR FR9507366A patent/FR2721930B1/fr not_active Expired - Fee Related
- 1995-06-21 EP EP95401463A patent/EP0692535A1/fr not_active Withdrawn
- 1995-06-21 FR FR9507367A patent/FR2721827A1/fr active Pending
- 1995-06-23 US US08/494,301 patent/US5856461A/en not_active Expired - Fee Related
- 1995-06-26 ZA ZA955288A patent/ZA955288B/xx unknown
- 1995-06-26 TN TNTNSN95068A patent/TNSN95068A1/fr unknown
- 1995-06-26 SK SK838-95A patent/SK83895A3/sk unknown
- 1995-06-27 DZ DZ950080A patent/DZ1903A1/fr active
- 1995-06-27 CZ CZ19951688A patent/CZ291496B6/cs not_active IP Right Cessation
- 1995-06-27 AU AU23299/95A patent/AU689887B2/en not_active Ceased
- 1995-06-27 FI FI953170A patent/FI953170A/fi unknown
- 1995-06-28 IE IE950477A patent/IE950477A1/en not_active IP Right Cessation
- 1995-06-28 NO NO952601A patent/NO952601L/no not_active Application Discontinuation
- 1995-06-28 RU RU95110774/04A patent/RU2112766C1/ru not_active IP Right Cessation
- 1995-06-28 HU HU9501913A patent/HU219823B/hu not_active IP Right Cessation
- 1995-06-28 MA MA23939A patent/MA23595A1/fr unknown
- 1995-06-28 CN CN95108109A patent/CN1124142A/zh active Pending
- 1995-06-28 KR KR1019950017763A patent/KR960000914A/ko not_active Application Discontinuation
- 1995-06-28 PL PL95309384A patent/PL309384A1/xx unknown
- 1995-06-29 OA OA60679A patent/OA10221A/fr unknown
- 1995-06-29 GB GB9513246A patent/GB2290791B/en not_active Expired - Fee Related
- 1995-06-29 JP JP7163358A patent/JPH0851985A/ja active Pending
- 1995-06-29 BR BR9503015A patent/BR9503015A/pt not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE200677T1 (de) | Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase | |
ATE397621T1 (de) | Hemmer der interaktion zwischen p53 und mdm2 | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
NO992400L (no) | Nye substituerte pyrazolderivater | |
DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
NO965604L (no) | Histidin- og homohistidin-derivater som inhibitorer for protein-farnesyltransferase | |
NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
DE50310516D1 (de) | Fredericamycin-derivate | |
NO20051966L (no) | Nye pyrimidinamidderivater og anvendelse derav | |
BRPI0518315B8 (pt) | compostos de tiazol que modulam a atividade da proteína hsp90, métodos de inibição, tratamento e indução associados e composição farmacêutica | |
CY1105125T1 (el) | Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων | |
SE9800836D0 (sv) | New Compounds | |
NO20051404L (no) | Pyridylsubstituerte heterocykluser som er nyttige for behandling eller forebyggelse av HCV infeksjon | |
DK0662948T3 (da) | 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning | |
GR910100067A (el) | Αναστολείς αρωματάσης. | |
ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
NO952601L (no) | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
NO20030802L (no) | Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme | |
ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
NO20006547L (no) | Salter av paroxetine | |
BR0015121A (pt) | Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação | |
DE60010934D1 (de) | Medikamente geeignet zur Behandlung von proliferativen Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |